Rachel Gowland, 16 February 2022
New FeNO in Asthma elearning is available
Health Education England elearning for healthcare worked in partnership with NHS England and NHS Improvement, Accelerated Access Collaborative, Wessex AHSN Network and the Office for Life Sciences to develop new elearning modules, focused on FeNO in Asthma. Although developed for primary care professionals, other healthcare professionals may find the modules useful.
What is FeNO?
FeNO (Fractional exhaled Nitric Oxide), is a test for measuring the amount of Nitric Oxide in the exhaled breath of patients. The results of the test can help with the diagnosis of asthma, by showing the level of inflammation in the lungs. A patient’s FeNO level helps improve the accuracy of asthma diagnosis and helps indicate which medications will work best for them.
About the new elearning module
The new module focuses on the interpretation of FeNO, providing an enhanced description of what FeNO is and how it can be used in the diagnosis of asthma, with case examples covering a spectrum of clinical scenarios.
An existing, introductory module aims to improve the learner’s understanding of FeNO, how the test is performed and appropriate language to use when talking about FeNO with patients.
More information
Healthcare professionals who are interested in the FeNO elearning modules can learn about them from a clinical champion in the virtual FeNO Learning Collaborative on Tuesday 15 March. Hosted by Wessex AHSN, read about the event and register for a place now.
To access the FeNO deployment toolkit, visit the Wessex ASHN website.
For further details on the AAC FeNO programme, visit the NHS England website.
Access the elearning
You can read more about the FeNO elearning modules, including how to access them, by visiting the programme page.
If you wish to leave feedback on the elearning modules, please complete the evaluation survey.
Comments are closed.